YAHOY Quote, Financials, Valuation and Earnings

Linkage Global has a net margin of 8.03% compared to LY's net margin of --. LY's return on equity of 4.52% beat Linkage Global's return on equity of -42.09%.

LY has a consensus price target of --, signalling downside risk potential of --. On the other hand Linkage Global has an analysts' consensus of -- which suggests that it could fall by --. Given that LY has higher upside potential than Linkage Global, analysts believe LY is more attractive than Linkage Global.

LY has a beta of 0.795, which suggesting that the stock is 20.492% less volatile than S&P 500. In comparison Linkage Global has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

LY has a quarterly dividend of $0.10 per share corresponding to a yield of 1.39%. Linkage Global offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LY pays 27.19% of its earnings as a dividend. Linkage Global pays out -- of its earnings as a dividend. LY's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

LY quarterly revenues are $3.3B, which are larger than Linkage Global quarterly revenues of --. LY's net income of $265M is higher than Linkage Global's net income of --. Notably, LY's price-to-earnings ratio is 25.21x while Linkage Global's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LY is 2.02x versus 0.48x for Linkage Global. Usually stocks with elevated PS ratios are considered overvalued.

MEDIROM Healthcare Technologies has a net margin of 8.03% compared to LY's net margin of --. LY's return on equity of 4.52% beat MEDIROM Healthcare Technologies's return on equity of --.

LY has a consensus price target of --, signalling downside risk potential of --. On the other hand MEDIROM Healthcare Technologies has an analysts' consensus of $4.98 which suggests that it could grow by 258.59%. Given that MEDIROM Healthcare Technologies has higher upside potential than LY, analysts believe MEDIROM Healthcare Technologies is more attractive than LY.

LY has a beta of 0.795, which suggesting that the stock is 20.492% less volatile than S&P 500. In comparison MEDIROM Healthcare Technologies has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

LY has a quarterly dividend of $0.10 per share corresponding to a yield of 1.39%. MEDIROM Healthcare Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LY pays 27.19% of its earnings as a dividend. MEDIROM Healthcare Technologies pays out -- of its earnings as a dividend. LY's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

LY quarterly revenues are $3.3B, which are larger than MEDIROM Healthcare Technologies quarterly revenues of --. LY's net income of $265M is higher than MEDIROM Healthcare Technologies's net income of --. Notably, LY's price-to-earnings ratio is 25.21x while MEDIROM Healthcare Technologies's PE ratio is 6.82x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LY is 2.02x versus 0.15x for MEDIROM Healthcare Technologies. Usually stocks with elevated PS ratios are considered overvalued.

NSK has a net margin of 8.03% compared to LY's net margin of 0.99%. LY's return on equity of 4.52% beat NSK's return on equity of 1.57%.

LY has a consensus price target of --, signalling downside risk potential of --. On the other hand NSK has an analysts' consensus of -- which suggests that it could fall by --. Given that LY has higher upside potential than NSK, analysts believe LY is more attractive than NSK.

LY has a beta of 0.795, which suggesting that the stock is 20.492% less volatile than S&P 500. In comparison NSK has a beta of 0.407, suggesting its less volatile than the S&P 500 by 59.278%.

LY has a quarterly dividend of $0.10 per share corresponding to a yield of 1.39%. NSK offers a yield of 5.15% to investors and pays a quarterly dividend of $0.23 per share. LY pays 27.19% of its earnings as a dividend. NSK pays out 146.95% of its earnings as a dividend. LY's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but NSK's is not.

LY quarterly revenues are $3.3B, which are larger than NSK quarterly revenues of $1.3B. LY's net income of $265M is higher than NSK's net income of $12.9M. Notably, LY's price-to-earnings ratio is 25.21x while NSK's PE ratio is 31.38x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LY is 2.02x versus 0.42x for NSK. Usually stocks with elevated PS ratios are considered overvalued.

Tokyo Lifestyle has a net margin of 8.03% compared to LY's net margin of --. LY's return on equity of 4.52% beat Tokyo Lifestyle's return on equity of -1.49%.

LY has a consensus price target of --, signalling downside risk potential of --. On the other hand Tokyo Lifestyle has an analysts' consensus of -- which suggests that it could fall by --. Given that LY has higher upside potential than Tokyo Lifestyle, analysts believe LY is more attractive than Tokyo Lifestyle.

LY has a beta of 0.795, which suggesting that the stock is 20.492% less volatile than S&P 500. In comparison Tokyo Lifestyle has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

LY has a quarterly dividend of $0.10 per share corresponding to a yield of 1.39%. Tokyo Lifestyle offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LY pays 27.19% of its earnings as a dividend. Tokyo Lifestyle pays out -- of its earnings as a dividend. LY's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

LY quarterly revenues are $3.3B, which are larger than Tokyo Lifestyle quarterly revenues of --. LY's net income of $265M is higher than Tokyo Lifestyle's net income of --. Notably, LY's price-to-earnings ratio is 25.21x while Tokyo Lifestyle's PE ratio is 1.82x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LY is 2.02x versus 0.09x for Tokyo Lifestyle. Usually stocks with elevated PS ratios are considered overvalued.